Recursion Pharmaceuticals
RXRX
#5297
Rank
S$1.97 B
Marketcap
S$3.16
Share price
-9.93%
Change (1 day)
-40.01%
Change (1 year)

Market capitalization of Recursion Pharmaceuticals (RXRX)

Market cap: S$1.97 Billion

As of November 2026 Recursion Pharmaceuticals has a market cap of S$1.97 Billion. This makes Recursion Pharmaceuticals the world's 5297th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Recursion Pharmaceuticals from 2021 to 2026

End of year Market Cap

Year Marketcap Change
2026S$1.97 B-30.73%
2025S$2.84 B-27.53%
2024S$3.92 B39.62%
2023S$2.81 B43.48%
2022S$1.95 B-49.94%
2021S$3.91 B

End of Day market cap according to different sources

On Nov 20th, 2026 the market cap of Recursion Pharmaceuticals was reported to be:

S$1.96 Billion
by Nasdaq info icon info icon
S$1.97 Billion
by CompaniesMarketCap info icon info icon